PPT-Pharmacovigilance 1 Dr. Ganesh Uchit

MD Pfizer India DISCLAIMER Overview Introduction amp Terminology Why Pharmacovigilance Pharmacovigilance Practices International amp Indian PVPI Drug Safety Issues in Clinical Trials . If you have a question on signal managem ent that is not addressed in this document please send it to pv helpdeskemaeuropaeu Note his document has been produced for guidance only and should be read in conjunction with Directive 200183EC Regulation E . Santosh Ostwal, CEO. . Rajashree. Ostwal, Director. . Ossian Agro Automation Pvt. Ltd.. (2010) . Formerly Ossian Agro Automation (1996). 9 April EMA/816573/2011Rev 1* Draft agreed by ERMS FG24 January 2012 Draft adopted by Executive Director20 February 2012 Released for consultation21 February 2012 End of consultation (deadline for co New challenges for WHO. Dr Shanthi Pal. . Group Lead, Medicines Safety . . Director/EMP . K. De . Joncheere. Coordinator PAU. G. Forte. Head/RHT. L.Rago. Coordinator/PHI. M Zafar. Coordinator /PQT. Draft Revision 1 agreed by ERMS FG29 May 2013 Draft Revision 1 adopted by Executive Director6 June 2013 Released for public consultation7 June 2013 nd of consultation (deadline for comments)5 August 2 New challenges for WHO. Dr Shanthi Pal. . Group Lead, Medicines Safety . . Director/EMP . K. De . Joncheere. Coordinator PAU. G. Forte. Head/RHT. L.Rago. Coordinator/PHI. M Zafar. Coordinator /PQT. Shanthi Pal. Leader, Medicines Safety. Safety . and Vigilance,. WHO, Geneva. What is pharmacovigilance. The science and activities relating to the detection, assessment, understanding and prevention of . Open Access Publications. and worldwide international science conferences and events. Established in the year 2007 with the sole aim of making the information on Sciences and technology ‘Open Access’, OMICS Group publishes 500 online open access . Prospects and Challenges of Providing Pharmacovigilance Services in Resource Limited Countries Avong YK 1 , Jatau B 1 , Ekong E 1 , Ndembi N 1 , Okuma J 1 , Obieze AI 2 , Osakwe A 2 , Create immense value with strategic, operationalSecrets to create exclusive and long-term Overcome “internal myopia” and its crippling large sales contract deals succeeda 360-degree view pu ARVs: Focus on Toxicity Monitoring . and Surveillance of DTG during pregnancy to inform treatment policy . Adele Schwartz Benzaken. . Department . of . STI, . HIV/AIDS . and Viral . Hepatitis. Ministry . If you are looking to buy a Ganesha idol for your home mandir, you must check out Satguru’s. This home decor shop in Mumbai has one of the best Ganesha idol collections. They also have an online store where you can purchase their products and have them delivered to your doorstep. Aside from Ganesha idols, you can also buy Ganesha paintings, landscape oil paintings, home decor items, and wall arts. Visit their website to learn more about their home decor items. No medicine is without . risk and the.  . benefits of . a medicine must always be weighed up against its risks. . The . balance of benefits and risks should be effectively considered and must not be left to chance. A public hearing is a forum to which the public is invited to express its views and concerns on a pre-defined set of questions on issues related to the safety of a particular medicine while also considering its therapeutic effects..